Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05607147 · ClinicalTrials.gov registry record · NA

Rutgers Pilot for Dental Health Care Worker SARS-CoV-2 Testing

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05607147: Completed NA study, sponsored by Rutgers, The State University of New Jersey.

NCT05607147 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05607147, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

10 asymptomatic DHCWs in the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated DHCWs' perceptions of safety and adoption of risk mitigation behavior. Following a baseline survey, finger-prick blood samples were collected twice two weeks apart using an innovative microsampling technique that replaces the need for venipuncture. Samples were processed using an in-house ELISA assay to detect IgM and IgG directed against the Receptor Binding Domain (RBD) of the Spike protein. Weekly Rapid Antigen testing of nasal swab specimens was used to document Antigen negativity during the study.

Primary Outcome

Number of Dental Health Care Workers (DHCWs) approached to enroll 10 consenting subjects to participate in the study

Interventions

  • DEVICE Testing for SARS CoV2 Antigen and Antibody

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-01-26
Est. Completion 2021-02-11
Phase NA

What the finished NCT05607147 record still lists

NCT05607147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Testing for SARS CoV2 Antigen and Antibody is the first listed.

NCT05607147 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05607147 about?

NCT05607147 is a clinical study titled "Rutgers Pilot for Dental Health Care Worker SARS-CoV-2 Testing". 10 asymptomatic DHCWs in the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated DHCWs' perceptions of safety and adoption of risk mitigation behavior. Following a baseline survey, fin...

What is the current status of trial NCT05607147?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-01-26. Estimated completion is 2021-02-11.

What interventions are being tested in trial NCT05607147?

The interventions under investigation include: Testing for SARS CoV2 Antigen and Antibody (DEVICE).

Who is sponsoring clinical trial NCT05607147?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05607147's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05607147, the US trial registry maintained by the National Library of Medicine. NCT05607147 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.